Literature DB >> 25822667

Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma.

Fiorella Faggi1, Nicola Chiarelli2, Marina Colombi2, Stefania Mitola2, Roberto Ronca2, Luca Madaro3, Marina Bouche3, Pietro L Poliani2, Marika Vezzoli2, Francesca Longhena2, Eugenio Monti2, Barbara Salani4, Davide Maggi4, Charles Keller5, Alessandro Fanzani1.   

Abstract

Rhabdomyosarcoma (RMS) is a childhood soft tissue tumor with broad expression of markers that are typically found in skeletal muscle. Cavin-1 is a recently discovered protein actively cooperating with Caveolin-1 (Cav-1) in the morphogenesis of caveolae and whose role in cancer is drawing increasing attention. Using a combined in silico and in vitro analysis here we show that Cavin-1 is expressed in myogenic RMS tumors as well as in human and primary mouse RMS cultures, exhibiting a broad subcellular localization, ranging from nuclei and cytosol to plasma membrane. In particular, the coexpression and plasma membrane interaction between Cavin-1 and Cav-1 characterized the proliferation of human and mouse RMS cell cultures, while a downregulation of their expression levels was observed during the myogenic differentiation. Knockdown of Cavin-1 or Cav-1 in the human RD and RH30 cells led to impairment of cell proliferation and migration. Moreover, loss of Cavin-1 in RD cells impaired the anchorage-independent cell growth in soft agar. While the loss of Cavin-1 did not affect the Cav-1 protein levels in RMS cells, Cav-1 overexpression and knockdown triggered a rise or depletion of Cavin-1 protein levels in RD cells, respectively, in turn reflecting on increased or decreased cell proliferation, migration and anchorage-independent cell growth. Collectively, these data indicate that the interaction between Cavin-1 and Cav-1 underlies the cell growth and migration in myogenic tumors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25822667     DOI: 10.1038/labinvest.2015.45

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  106 in total

1.  Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.

Authors:  M R Stratton; C Fisher; B A Gusterson; C S Cooper
Journal:  Cancer Res       Date:  1989-11-15       Impact factor: 12.701

2.  Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells.

Authors:  P L Lollini; C De Giovanni; L Landuzzi; G Nicoletti; K Scotlandi; P Nanni
Journal:  Invasion Metastasis       Date:  1991

3.  Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations.

Authors:  Savitha Shastry; Mauricio R Delgado; Eray Dirik; Mehmet Turkmen; Anil K Agarwal; Abhimanyu Garg
Journal:  Am J Med Genet A       Date:  2010-09       Impact factor: 2.802

4.  Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells.

Authors:  Simone Hettmer; Jianing Liu; Christine M Miller; Melissa C Lindsay; Cynthia A Sparks; David A Guertin; Roderick T Bronson; David M Langenau; Amy J Wagers
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-30       Impact factor: 11.205

5.  PTRF (polymerase I and transcript-release factor) is tissue-specific and interacts with the BFCOL1 (binding factor of a type-I collagen promoter) zinc-finger transcription factor which binds to the two mouse type-I collagen gene promoters.

Authors:  T Hasegawa; A Takeuchi; O Miyaishi; H Xiao; J Mao; K Isobe
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

6.  Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.

Authors:  A Astolfi; C De Giovanni; L Landuzzi; G Nicoletti; C Ricci; S Croci; L Scopece; P Nanni; P L Lollini
Journal:  Gene       Date:  2001-08-22       Impact factor: 3.688

7.  Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.

Authors:  Karen Fernandez; Yelda Serinagaoglu; Sue Hammond; Laura T Martin; Paul T Martin
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

8.  Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.

Authors:  James G Taylor; Adam T Cheuk; Patricia S Tsang; Joon-Yong Chung; Young K Song; Krupa Desai; Yanlin Yu; Qing-Rong Chen; Kushal Shah; Victoria Youngblood; Jun Fang; Su Young Kim; Choh Yeung; Lee J Helman; Arnulfo Mendoza; Vu Ngo; Louis M Staudt; Jun S Wei; Chand Khanna; Daniel Catchpoole; Stephen J Qualman; Stephen M Hewitt; Glenn Merlino; Stephen J Chanock; Javed Khan
Journal:  J Clin Invest       Date:  2009-10-05       Impact factor: 14.808

9.  A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization.

Authors:  Libin Liu; Paul F Pilch
Journal:  J Biol Chem       Date:  2007-12-03       Impact factor: 5.157

10.  Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.

Authors:  Francesco Marampon; Carmela Ciccarelli; Bianca M Zani
Journal:  Mol Cancer       Date:  2006-08-09       Impact factor: 27.401

View more
  15 in total

1.  Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.

Authors:  Qing Guo; Ge-Fei Guan; Wen Cheng; Cun-Yi Zou; Chen Zhu; Peng Cheng; An-Hua Wu
Journal:  CNS Neurosci Ther       Date:  2018-10-11       Impact factor: 5.243

2.  Fluctuation of ROS regulates proliferation and mediates inhibition of migration by reducing the interaction between DLC1 and CAV-1 in breast cancer cells.

Authors:  Bingwu Yang; Wenzhen Zhu; Zhaodi Zheng; Rongfei Chai; Shuhua Ji; Guanghui Ren; Tingting Liu; Zhaojun Liu; Taiyu Song; Fenglin Li; Shan Liu; Guorong Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-01-27       Impact factor: 2.416

3.  MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF.

Authors:  Ming Bai; Mingzi Zhang; Fei Long; Nanze Yu; Ang Zeng; Xiaojun Wang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

4.  MicroRNA-451a targets caveolin-1 in stomach cancer cells.

Authors:  Yi Wang; Zhenmeng Lin; Jintian Song; Shenghong Wei; Zaisheng Ye; Shu Chen; Yi Zeng; Zhitao Lin; Xiaoling Chen; Luchuan Chen
Journal:  Int J Clin Exp Pathol       Date:  2020-10-01

5.  NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.

Authors:  Francesco Marampon; Silvia Codenotti; Francesca Megiorni; Andrea Del Fattore; Simona Camero; Giovanni Luca Gravina; Claudio Festuccia; Daniela Musio; Francesca De Felice; Valerio Nardone; Anna Natalizia Santoro; Carlo Dominici; Alessandro Fanzani; Luigi Pirtoli; Antonella Fioravanti; Vincenzo Tombolini; Sara Cheleschi; Paolo Tini
Journal:  J Cancer Res Clin Oncol       Date:  2019-01-30       Impact factor: 4.553

6.  Caveolin-1 overexpression in benign and malignant salivary gland tumors.

Authors:  Zohreh Jaafari-Ashkavandi; Mohammad Javad Ashraf; Ali Dehghani Nazhvani; Zahra Azizi
Journal:  Tumour Biol       Date:  2015-09-01

7.  Stromal CAVIN1 Controls Prostate Cancer Microenvironment and Metastasis by Modulating Lipid Distribution and Inflammatory Signaling.

Authors:  Jin-Yih Low; W Nathaniel Brennen; Alan K Meeker; Elina Ikonen; Brian W Simons; Marikki Laiho
Journal:  Mol Cancer Res       Date:  2020-06-03       Impact factor: 5.852

8.  MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.

Authors:  Fiorella Faggi; Silvia Codenotti; Pietro Luigi Poliani; Manuela Cominelli; Nicola Chiarelli; Marina Colombi; Marika Vezzoli; Eugenio Monti; Federica Bono; Giovanni Tulipano; Chiara Fiorentini; Alessandra Zanola; Harriet P Lo; Robert G Parton; Charles Keller; Alessandro Fanzani
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

Review 9.  Caveolin-1 in the regulation of cell metabolism: a cancer perspective.

Authors:  Zeribe Chike Nwosu; Matthias Philip Ebert; Steven Dooley; Christoph Meyer
Journal:  Mol Cancer       Date:  2016-11-16       Impact factor: 27.401

10.  CAV1 rs7804372 (T29107A) polymorphism might be a potential risk for digestive cancers: A protocol for systematic review and meta analysis.

Authors:  Pei Chen; Yu-Ling Zhang; Bai Xue; Ji-Ru Wang
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.